These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15320754)

  • 21. Expression and localization of delta-, kappa-, and mu-opioid receptors in human spermatozoa and implications for sperm motility.
    Agirregoitia E; Valdivia A; Carracedo A; Casis L; Gil J; Subiran N; Ochoa C; Irazusta J
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4969-75. PubMed ID: 16984994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors.
    Vanderah TW; Largent-Milnes T; Lai J; Porreca F; Houghten RA; Menzaghi F; Wisniewski K; Stalewski J; Sueiras-Diaz J; Galyean R; Schteingart C; Junien JL; Trojnar J; Rivière PJ
    Eur J Pharmacol; 2008 Mar; 583(1):62-72. PubMed ID: 18282565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central and systemic kappa-opioid agonists exacerbate neurobehavioral response to brain injury in rats.
    McIntosh TK; Fernyak S; Yamakami I; Faden AI
    Am J Physiol; 1994 Sep; 267(3 Pt 2):R665-72. PubMed ID: 7916537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of glutamate and gamma-amino-butyric acid receptor systems on gastric acid secretion induced by activation of kappa-opioid receptors in the central nervous system in rats.
    Minowa S; Ishihara S; Tsuchiya S; Horie S; Watanabe K; Murayama T
    Br J Pharmacol; 2003 Mar; 138(6):1049-58. PubMed ID: 12684260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic sucrose intake augments antinociception induced by injections of mu but not kappa opioid receptor agonists into the periaqueductal gray matter in male and female rats.
    Kanarek RB; Mandillo S; Wiatr C
    Brain Res; 2001 Nov; 920(1-2):97-105. PubMed ID: 11716815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-methylacetamide analog of salvinorin A: a highly potent and selective kappa-opioid receptor agonist with oral efficacy.
    Béguin C; Potter DN; Dinieri JA; Munro TA; Richards MR; Paine TA; Berry L; Zhao Z; Roth BL; Xu W; Liu-Chen LY; Carlezon WA; Cohen BM
    J Pharmacol Exp Ther; 2008 Jan; 324(1):188-95. PubMed ID: 17951511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of opioid delta (delta) and kappa ( kappa) receptors' cardioprotection in ischaemic preconditioning in a rat model of myocardial infarction.
    Valtchanova-Matchouganska A; Ojewole JA
    Cardiovasc J S Afr; 2003; 14(2):73-80. PubMed ID: 12748744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of kappa and delta opioid receptors in isolated organs by using type/subtype selective agonists and antagonists.
    Makó E; Rónai AZ
    Med Sci Monit; 2001; 7(3):350-6. PubMed ID: 11386008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of repeated administration of TRK-820, a kappa-opioid receptor agonist, on tolerance to its antinociceptive and sedative actions.
    Suzuki T; Izumimoto N; Takezawa Y; Fujimura M; Togashi Y; Nagase H; Tanaka T; Endoh T
    Brain Res; 2004 Jan; 995(2):167-75. PubMed ID: 14672806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of kappa-opioid receptor agonists on tetrodotoxin-resistant sodium channels in primary sensory neurons.
    Su X; Castle NA; Antonio B; Roeloffs R; Thomas JB; Krafte DS; Chapman ML
    Anesth Analg; 2009 Aug; 109(2):632-40. PubMed ID: 19608841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-inflammatory effects of opioids.
    Walker JS
    Adv Exp Med Biol; 2003; 521():148-60. PubMed ID: 12617572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pentazocine-induced antinociception is mediated mainly by μ-opioid receptors and compromised by κ-opioid receptors in mice.
    Shu H; Hayashida M; Arita H; Huang W; Zhang H; An K; Wu G; Hanaoka K
    J Pharmacol Exp Ther; 2011 Aug; 338(2):579-87. PubMed ID: 21543510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Participation of central kappa-opioid receptor in arrhythmogenesis.
    Lishmanov YB; Maslov LN; Ugdyzhekova DS; Smagin GN
    Life Sci; 1997; 61(3):PL33-8. PubMed ID: 9217295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of kappa-opioid and sigma receptors in short-term memory in mice.
    Hiramatsu M; Hoshino T; Kameyama T; Nabeshima T
    Eur J Pharmacol; 2002 Oct; 453(1):91-8. PubMed ID: 12393064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional interaction between alpha2-adrenoceptors, mu- and kappa-opioid receptors in the guinea pig myenteric plexus: effect of chronic desipramine treatment.
    Canciani L; Giaroni C; Zanetti E; Giuliani D; Pisani R; Moro E; Trinchera M; Crema F; Lecchini S; Frigo G
    Eur J Pharmacol; 2006 Dec; 553(1-3):269-79. PubMed ID: 17055479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel phenylamino acetamide derivatives as potent and selective kappa opioid receptor agonists.
    Chu GH; Gu M; Cassel JA; Belanger S; Stabley GJ; DeHaven RN; Conway-James N; Koblish M; Little PJ; DeHaven-Hudkins DL; Dolle RE
    Bioorg Med Chem Lett; 2006 Feb; 16(3):645-8. PubMed ID: 16263278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans.
    Machelska H; Pflüger M; Weber W; Piranvisseh-Völk M; Daubert JD; Dehaven R; Stein C
    J Pharmacol Exp Ther; 1999 Jul; 290(1):354-61. PubMed ID: 10381799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Pharmacological Heterogeneity of Nepenthone Analogs in Conferring Highly Selective and Potent κ-Opioid Agonistic Activities.
    Li W; Long JD; Qian YY; Long Y; Xu XJ; Wang YJ; Shen Q; Wang ZN; Yang XC; Xiao L; Sun HP; Xu YL; Chen YY; Xie Q; Wang YH; Shao LM; Liu JG; Qiu ZB; Fu W
    ACS Chem Neurosci; 2017 Apr; 8(4):766-776. PubMed ID: 28033462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of mu-, delta- and kappa-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice.
    Mori T; Ito S; Kita T; Narita M; Suzuki T; Sawaguchi T
    Eur J Pharmacol; 2006 Feb; 532(1-2):81-7. PubMed ID: 16464448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
    Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.